Literature DB >> 17082624

IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses.

John J Lazarus1, Michelle J Meadows, Robert E Lintner, R Mark Wooten.   

Abstract

Borrelia burgdorferi is capable of persistently infecting a variety of hosts despite eliciting potent innate and adaptive immune responses. Preliminary studies indicated that IL-10-deficient (IL-10(-/-)) mice exhibit up to 10-fold greater clearance of B. burgdorferi from target tissues compared with wild-type mice, establishing IL-10 as the only cytokine currently known to have such a significant effect on spirochetal clearance. To further delineate these IL-10-mediated immune effects, kinetic studies indicated that spirochete dissemination to target tissues is similar in both wild-type and IL-10(-/-) mouse strains, and that enhanced clearance of B. burgdorferi in IL-10(-/-) mice is correlated with increased B. burgdorferi-specific Ab as early as 2 wk postinfection. Immunoblot analysis indicated that Abs produced by infected IL-10(-/-) and wild-type mice recognize similar ranges of spirochetal Ags. Immune sera from IL-10(-/-) and wild-type mice also exhibited similar bactericidal activity in vitro, and passive transfer of these immune sera into B. burgdorferi-infected SCID mice caused similar reductions of bacterial numbers in target tissues. Infectious dose studies indicated that 8-fold more B. burgdorferi were needed to efficiently infect naive IL-10(-/-) mice, suggesting these animals possess higher innate barriers to infection. Moreover, macrophages derived from IL-10(-/-) mice exhibit enhanced proinflammatory responses to B. burgdorferi stimulation compared with wild-type controls, and these responses are not significantly affected by the presence of immune serum. These findings confirm that B. burgdorferi clearance by innate immune responses is more efficient in the absence of IL-10, and these activities are not directly related to increased levels of B. burgdorferi-specific Ab.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082624     DOI: 10.4049/jimmunol.177.10.7076

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

2.  Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling.

Authors:  Bikash Sahay; Kathleen Bashant; Nicole L J Nelson; Rebeca L Patsey; Shiva Kumar Gadila; Rebecca Boohaker; Ashutosh Verma; Klemen Strle; Timothy J Sellati
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  BB0744 Affects Tissue Tropism and Spatial Distribution of Borrelia burgdorferi.

Authors:  Beau Wager; Dana K Shaw; Ashley M Groshong; Jon S Blevins; Jon T Skare
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

4.  Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation.

Authors:  Aarti Gautam; Saurabh Dixit; Mario T Philipp; Shree R Singh; Lisa A Morici; Deepak Kaushal; Vida A Dennis
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 5.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

6.  Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis.

Authors:  F Lynn Sonderegger; Ying Ma; Heather Maylor-Hagan; James Brewster; Xiaosong Huang; Gerald J Spangrude; James F Zachary; John H Weis; Janis J Weis
Journal:  J Immunol       Date:  2011-12-16       Impact factor: 5.422

7.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease.

Authors:  Charles R Brown; Annie Y-C Lai; Steven T Callen; Victoria A Blaho; Jennifer M Hughes; William J Mitchell
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

Review 9.  Regulation of T-helper-cell lineage development by osteopontin: the inside story.

Authors:  Harvey Cantor; Mari L Shinohara
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

10.  Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.

Authors:  Lei Sun; Ren-Feng Guo; Michael W Newstead; Theodore J Standiford; Demetrio R Macariola; Thomas P Shanley
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.